Aemetis (NASDAQ:AMTX) Issues Quarterly Earnings Results, Misses Expectations By $0.25 EPS

Aemetis (NASDAQ:AMTX) posted its quarterly earnings results on Thursday. The specialty chemicals company reported ($0.66) EPS for the quarter, missing analysts’ consensus estimates of ($0.41) by ($0.25), Zacks reports. The company had revenue of $66.56 million during the quarter, compared to the consensus estimate of $75.37 million. During the same quarter in the previous year, the company posted ($0.68) earnings per share.

Aemetis Stock Down 7.1 %

AMTX traded down $0.19 on Friday, hitting $2.47. The company had a trading volume of 1,353,332 shares, compared to its average volume of 896,229. The company has a market cap of $109.67 million, a PE ratio of -2.07 and a beta of 1.32. Aemetis has a 12-month low of $2.29 and a 12-month high of $7.82. The business’s fifty day simple moving average is $3.28 and its 200 day simple moving average is $3.70.

Insider Transactions at Aemetis

In other Aemetis news, Director John R. Block sold 51,580 shares of the business’s stock in a transaction on Thursday, May 23rd. The shares were sold at an average price of $3.49, for a total transaction of $180,014.20. Following the transaction, the director now owns 14,001 shares in the company, valued at $48,863.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 14.34% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the stock. HC Wainwright reiterated a “buy” rating and issued a $28.00 price target on shares of Aemetis in a report on Friday. StockNews.com upgraded Aemetis to a “sell” rating in a research report on Wednesday. Finally, Truist Financial reissued a “hold” rating and set a $3.50 price target (down from $4.00) on shares of Aemetis in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $12.13.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.